Alfehaid, L., Alanazi, A., Alsuhebany, N., Alamer, K., Skouri, H. N. (2026). Multi-center real-world validation of the HFA-ICOS cardio-oncology risk tool in HER2-positive breast cancer patients receiving anti-HER2 therapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e24015